Weight loss
Retatrutide - Pre-Filled Pens
Retatrutide, the investigational GIP / GLP-1 / glucagon triple agonist, supplied in pre-filled pens.
- Third-party tested · certificate of analysis
- EU shipping · discreet delivery, free over €459.99
- Card, Apple Pay, Google Pay or crypto
Overview
This is the same compound as our retatrutide vials, supplied in sealed pre-filled pens instead of lyophilised powder, so no reconstitution is needed.
Retatrutide activates three receptors involved in energy balance: GIP, GLP-1 and glucagon. It is still in clinical development, with phase 3 trials ongoing after a phase 2 obesity study published in 2023.
Research areas
- Body-weight regulation and energy expenditure
- Glycaemic control
- Liver fat and metabolic liver disease
- Multi-receptor incretin pharmacology
Specifications
- Category
- Weight loss
- Compound
- Synthetic peptide, GIP / GLP-1 / glucagon receptor triple agonist
- Structure
- Single-chain peptide with a fatty acid side chain (development code LY3437943)
- Form
- Pre-filled pens
- Available as
- 10mg (4 pens) · 20mg (4 pens)
- Quality
- Third-party tested · certificate of analysis available
Storage and handling
Keep refrigerated (2–8 °C). Do not freeze. Protect from light.
Sold strictly for laboratory research use only. Not for human consumption, and not intended to diagnose, treat, cure or prevent any disease.